contact@thedailystory.net
“Pfizer CEO: Cancer Becomes the New COVID” : Analysis
Reading Time (200 word/minute): 2 minutesPfizer is shifting focus to oncology as demand for Covid-19 products dwindles. Sales decreased significantly post-pandemic, leading to cost-cutting measures. The company acquired Seagen for $43 billion to bolster its cancer treatment portfolio. Drugs like…